Haemonetics Announces Proposed Convertible Senior Notes Offering
News provided by
Share this article
Share this article
BOSTON, March 1, 2021 /PRNewswire/ Haemonetics Corporation ( Haemonetics ) (NYSE: HAE) today announced its intention to offer, subject to market and other conditions, $425,000,000 aggregate principal amount of Convertible Senior Notes due 2026 (the notes ) in a private offering (the offering ) to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the Securities Act ). Haemonetics also expects to grant the initial purchasers of the notes an option to purchase up to an additional $63,750,000 aggregate principal amount of the notes.
The notes will be senior, unsecured obligations of Haemonetics, will accrue interest payable semi-annually in arrears, and will mature on March 1, 2026, unless earlier repurchased, redeemed or converted. Noteholders will have the right to convert their notes in certain circumstanc
Posted on 344
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today reports financial and operational results for the fourth quarter and year ended December 31, as well as guidance for anticipated 2021 milestones.
“2021 is poised to be another exciting year for Rocket,” said Gaurav Shah, M.D., Chief Executive Officer of Rocket. “We anticipate clinical data from all five of our gene therapy programs, initiation of our first in-house AAV cGMP production from our new manufacturing facility, and continued strengthening of our organization, manufacturing capabilities and infrastructure. We look forward to continued validation of our gene therapy platforms with updated results from registrational studies in FA and LAD-I, longer term findings in Danon Disease and PKD, and clinical proof-of-concept for
Press release content from PR Newswire. The AP news staff was not involved in its creation.
LivePerson Announces Fourth Quarter 2020 Financial Results
February 25, 2021 GMT
LivePerson Logo (PRNewsfoto/LivePerson, Inc.)
NEW YORK, Feb. 25, 2021 /PRNewswire/ LivePerson, Inc. (NASDAQ: LPSN), a global leader in conversational AI, today announced financial results for the fourth quarter ended December 31, 2020.
Fourth Quarter and 2020 Highlights
Total revenue was $102.1 million for the fourth quarter of 2020, an increase of 29% as compared to the same period last year. Within total revenue, business operations (B2B) revenue for the fourth quarter of 2020 increased 29% year over year to $94.1 million and revenue from consumer operations increased 29% to $8.1 million.
Author Bio
Travis Hoium has been writing for fool.com since July 2010 and covers the solar industry, renewable energy, and gaming stocks among other things. Follow @TravisHoium
What happened
Shares of solar supplier
Enphase Energy (NASDAQ:ENPH) plunged as much as 8.2% in trading on Thursday after the company announced a larger debt offering. Shares closed the day down 7.5%.
So what
Yesterday, Enphase Energy announced a $1 billion green bonds offering, which was intended to be $500 million of 2026 and 2028 convertible senior notes. Today, that offering was increased to $1.15 billion with an equal amount in 0% Convertible Senior Notes due 2026 and 0% Convertible Senior Notes due 2028. The pricing of the offering is expected to generate about $1.132 billion before any overallotment.